W
Waitemata Clinical Research Ltd. | Auckland, New Zealand
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
MK-0616
RBN-3143
BI 3034701
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 3 total trials
This study is open to adults between 18 and 74 years of age and who have a body mass index (BMI) of 30 kg/m2 or more, or a BMI of 27 kg/m2 or more an...
Enrolling
Overweight
Obesity
Drug: Placebo matching BI 3034701
Drug: BI 3034701
This is a phase 3, randomized, placebo-controlled study of the efficacy and safety of enlicitide decanoate, an oral proprotein convertase subtilisin/...
Active, not recruiting
Arteriosclerosis
Hypercholesterolaemia
Drug: Enlicitide Decanoate
Drug: Placebo
RBN-3143 Background: PARP proteins are members of a family of seventeen ADP-ribosyltransferase (ART) enzymes that regulate cellular processes includi...
Enrolling
Atopic Dermatitis
Drug: RBN-3143
Trial sponsors
R
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems